Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


European Commission authorises Apretude (cabotegravir long-acting and tablets) for HIV prevention – Viiv HealthCare

Written by | 24 Sep 2023

GSK plc announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders announced that the European Commission has authorised… read more.

UCLA’s HIV prevention and treatment center receives $7.5 million grant from NIH

Written by | 21 Mar 2022

The National Institute of Mental Health has renewed its support for UCLA’s collaborative Center for HIV Identification, Prevention and Treatment Services, or CHIPTS, with a five-year, $7.5 million grant. The… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.